USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 3rd. The shares were sold at an average price of $57.54, for a total transaction of $2,301,600.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

USANA Health Sciences, Inc. (USNA) opened at 58.05 on Friday. The firm has a 50-day moving average of $57.83 and a 200 day moving average of $60.11. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of 15.08 and a beta of 1.09. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.08). USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The company had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. During the same period in the previous year, the firm posted $2.07 EPS. The business’s quarterly revenue was down .5% compared to the same quarter last year. Analysts expect that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.

USANA Health Sciences announced that its board has initiated a share buyback plan on Tuesday, July 25th that allows the company to repurchase $64.60 million in outstanding shares. This repurchase authorization allows the company to purchase up to 46% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/myron-w-wentz-sells-40000-shares-of-usana-health-sciences-inc-usna-stock/1611700.html.

Several hedge funds and other institutional investors have recently bought and sold shares of USNA. Renaissance Technologies LLC raised its holdings in shares of USANA Health Sciences by 10.6% in the second quarter. Renaissance Technologies LLC now owns 1,948,266 shares of the company’s stock valued at $124,884,000 after purchasing an additional 186,600 shares during the last quarter. FMR LLC raised its holdings in shares of USANA Health Sciences by 7.1% in the first quarter. FMR LLC now owns 1,538,110 shares of the company’s stock valued at $88,595,000 after purchasing an additional 102,086 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of USANA Health Sciences by 711.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock valued at $5,859,000 after purchasing an additional 80,145 shares during the last quarter. Old Mutual Global Investors UK Ltd. raised its holdings in shares of USANA Health Sciences by 29.7% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 239,680 shares of the company’s stock valued at $15,363,000 after purchasing an additional 54,831 shares during the last quarter. Finally, Schroder Investment Management Group raised its holdings in shares of USANA Health Sciences by 9.0% in the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock valued at $36,734,000 after purchasing an additional 47,448 shares during the last quarter. Institutional investors own 44.87% of the company’s stock.

Several research analysts have weighed in on the stock. BidaskClub upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Pivotal Research dropped their price objective on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Wednesday, July 26th.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.